This clinical brief is intended to increase awareness among managed care decision-makers about the results of the CLEAR Outcomes trial, a cardiovascular outcomes trial for bempedoic acid, as well as foster informed decision-making among managed care decision-makers on the place in therapy for bempedoic acid in patients with high risk or with cardiovascular disease who need additional lipid lowering.